BXP, Inc. Q1 FY2025 earnings call

• Operating environment: Tariffs and federal policies create capital market volatility, inflation, interest rate concerns, and life science community faces headwinds from NIH funding cuts and FDA approval uncertainties.
• Office market conditions: Premier Workplaces outperform broader market in vacancy, net absorption, and rents.
• Capital allocation and new investments: Commenced 290 Kohl's multifamily project and 343 Madison office project; ongoing development pipeline with leasing activity.
• Leasing activity: Over 1.1 million sq ft leased in Q1, 25% above Q1 2024; robust pipeline with signed LOIs and negotiations.
• Sustainability: Released 2024 sustainability and impact report.

No detailed breakdown of product segments with revenue contribution percentages provided in the transcript.

• FFO per share midpoint for 2025 revised to $6.80 to $6.92 per share, narrowing the range due to leasing success and occupancy start timing.
• Leasing guidance for 2025 is 4 million sq ft, including 3 million sq ft on vacant space and 2025 expirations.

• Tariffs driving up material prices and construction costs, though impact on construction estimates is modest.
• Potential recession leading to slower leasing demand, though lower interest rates and reduced remote work could offset.
• Life science community headwinds from NIH funding cuts and FDA approval uncertainties.

Q: Steve Sakwa asks about 343 Madison's pre-leasing and yield target.

A: Unidentified Company Representative and Douglas Linde discuss pre-leasing interest and yield target of 8%.

Q: John Kim asks about confidence in 2025 leasing plan.

A: Douglas Linde responds on current leasing activity and pipeline.

Q: Nick Yulico asks about earnings impact from pipeline activity.

A: Michael LaBelle and Douglas Linde discuss range narrowing due to leasing success.

Q: Anthony Paolone asks about West Coast leasing activity.

A: Douglas Linde and Rodney Diehl discuss West Coast leasing trends.

Q: Blaine Heck asks about leverage and funding.

A: Michael LaBelle discusses leverage and funding strategies.

Q: Jana Galan asks about debt issuance in volatile markets.

A: Michael LaBelle comments on bond and CMBS market conditions.

Q: Alexander Goldfarb asks about FFO ramp in back half.

A: Michael LaBelle discusses FFO ramp expectations.

Q: Omotayo Okusanya asks about opportunities to exceed guidance.

A: Douglas Linde talks about opportunities for outsized leasing performance.

Q: Dylan Bazinsky asks about West Coast tenant downsizing.

A: Douglas Linde and Rodney Diehl discuss West Coast tenant behavior.

Q: Brendan Lynch asks about redevelopment project timelines.

A: Douglas Linde discusses redevelopment project timelines.

Q: Peter Abramowitz asks about 125 Broadway asset positioning.

A: Douglas Linde and Bryan Koop discuss 125 Broadway's repositioning.